 Jacob Mark
Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endosonography | 5 | 2025 | 154 | 1.900 |
Why?
| | Pancreatitis, Chronic | 8 | 2026 | 61 | 1.620 |
Why?
| | Abdominal Pain | 3 | 2026 | 143 | 1.540 |
Why?
| | Pancreatic Cyst | 2 | 2024 | 48 | 1.490 |
Why?
| | Endoscopy, Gastrointestinal | 5 | 2024 | 231 | 1.350 |
Why?
| | Pancreatitis | 5 | 2026 | 136 | 1.340 |
Why?
| | Foreign Bodies | 2 | 2023 | 108 | 1.280 |
Why?
| | Ultrasonography, Interventional | 3 | 2025 | 156 | 1.210 |
Why?
| | Botulinum Toxins, Type A | 2 | 2025 | 55 | 1.030 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 5 | 2025 | 213 | 1.030 |
Why?
| | Pancreas | 2 | 2025 | 326 | 0.930 |
Why?
| | Anal Canal | 2 | 2025 | 101 | 0.920 |
Why?
| | Constipation | 2 | 2025 | 96 | 0.890 |
Why?
| | Celiac Plexus | 1 | 2024 | 6 | 0.880 |
Why?
| | Dyspepsia | 1 | 2024 | 10 | 0.880 |
Why?
| | Esophagus | 3 | 2024 | 261 | 0.870 |
Why?
| | Neuromuscular Agents | 1 | 2025 | 44 | 0.870 |
Why?
| | Esophagoscopy | 3 | 2025 | 214 | 0.860 |
Why?
| | Ketorolac | 1 | 2021 | 25 | 0.710 |
Why?
| | Esophageal Stenosis | 2 | 2019 | 56 | 0.700 |
Why?
| | von Hippel-Lindau Disease | 1 | 2020 | 12 | 0.670 |
Why?
| | Duodenoscopes | 1 | 2020 | 7 | 0.640 |
Why?
| | Quarantine | 1 | 2020 | 31 | 0.620 |
Why?
| | Endoscopy | 2 | 2021 | 327 | 0.610 |
Why?
| | Esophageal Diseases | 1 | 2019 | 29 | 0.600 |
Why?
| | Single-Balloon Enteroscopy | 1 | 2018 | 4 | 0.590 |
Why?
| | Magnets | 1 | 2018 | 20 | 0.580 |
Why?
| | Dilatation | 1 | 2019 | 69 | 0.580 |
Why?
| | Catheterization | 1 | 2019 | 185 | 0.560 |
Why?
| | Bile Duct Diseases | 1 | 2018 | 12 | 0.560 |
Why?
| | Colonic Diseases | 1 | 2018 | 36 | 0.560 |
Why?
| | Child | 23 | 2026 | 22390 | 0.550 |
Why?
| | Self Expandable Metallic Stents | 1 | 2018 | 16 | 0.550 |
Why?
| | Intestine, Small | 1 | 2018 | 157 | 0.530 |
Why?
| | Recurrence | 6 | 2026 | 1108 | 0.500 |
Why?
| | Pancreatic Neoplasms | 1 | 2024 | 890 | 0.490 |
Why?
| | Eosinophilia | 1 | 2018 | 224 | 0.470 |
Why?
| | Colon | 1 | 2018 | 295 | 0.460 |
Why?
| | Patient Safety | 1 | 2018 | 335 | 0.440 |
Why?
| | Fellowships and Scholarships | 1 | 2018 | 326 | 0.430 |
Why?
| | Chronic Pain | 1 | 2018 | 281 | 0.420 |
Why?
| | Postoperative Complications | 3 | 2025 | 2831 | 0.410 |
Why?
| | Education, Medical, Graduate | 1 | 2018 | 529 | 0.400 |
Why?
| | Adolescent | 15 | 2026 | 22116 | 0.380 |
Why?
| | Child, Preschool | 10 | 2025 | 11511 | 0.360 |
Why?
| | Algorithms | 1 | 2018 | 1764 | 0.330 |
Why?
| | Clinical Competence | 1 | 2018 | 1210 | 0.320 |
Why?
| | Humans | 29 | 2026 | 141284 | 0.310 |
Why?
| | Pilot Projects | 2 | 2025 | 1820 | 0.300 |
Why?
| | Endoscopy, Digestive System | 3 | 2025 | 137 | 0.290 |
Why?
| | Retrospective Studies | 9 | 2025 | 16447 | 0.270 |
Why?
| | Acute Disease | 6 | 2026 | 1005 | 0.260 |
Why?
| | Prospective Studies | 4 | 2025 | 7805 | 0.250 |
Why?
| | Female | 17 | 2026 | 75814 | 0.250 |
Why?
| | Male | 16 | 2026 | 70140 | 0.240 |
Why?
| | Treatment Outcome | 6 | 2026 | 11216 | 0.230 |
Why?
| | Exocrine Pancreatic Insufficiency | 1 | 2025 | 23 | 0.230 |
Why?
| | Autonomic Nerve Block | 1 | 2024 | 10 | 0.220 |
Why?
| | Injections | 1 | 2025 | 191 | 0.220 |
Why?
| | Hypertriglyceridemia | 1 | 2024 | 39 | 0.220 |
Why?
| | Trypsin Inhibitor, Kazal Pancreatic | 1 | 2024 | 6 | 0.210 |
Why?
| | Patient Positioning | 1 | 2024 | 71 | 0.210 |
Why?
| | Islets of Langerhans Transplantation | 1 | 2024 | 65 | 0.210 |
Why?
| | Diagnosis, Differential | 2 | 2018 | 1491 | 0.210 |
Why?
| | Benzodioxoles | 1 | 2025 | 138 | 0.200 |
Why?
| | Deglutition | 1 | 2024 | 71 | 0.200 |
Why?
| | Transplantation, Autologous | 1 | 2024 | 282 | 0.200 |
Why?
| | Gastrointestinal Diseases | 1 | 2025 | 207 | 0.200 |
Why?
| | Nerve Block | 1 | 2024 | 97 | 0.200 |
Why?
| | Aminophenols | 1 | 2025 | 175 | 0.190 |
Why?
| | Operative Time | 2 | 2024 | 158 | 0.190 |
Why?
| | Triglycerides | 1 | 2024 | 510 | 0.180 |
Why?
| | Pain Management | 1 | 2026 | 397 | 0.180 |
Why?
| | Pancreatectomy | 1 | 2024 | 263 | 0.180 |
Why?
| | Indoles | 1 | 2025 | 472 | 0.180 |
Why?
| | Pyrazoles | 1 | 2025 | 482 | 0.180 |
Why?
| | Botulinum Toxins | 1 | 2022 | 45 | 0.170 |
Why?
| | Internet | 1 | 2026 | 683 | 0.170 |
Why?
| | Pancreatic Ducts | 1 | 2021 | 80 | 0.170 |
Why?
| | Gastroenterology | 1 | 2023 | 185 | 0.170 |
Why?
| | Evidence-Based Medicine | 1 | 2024 | 717 | 0.170 |
Why?
| | Quality of Life | 4 | 2026 | 3024 | 0.160 |
Why?
| | Pediatrics | 2 | 2018 | 1102 | 0.160 |
Why?
| | Equipment Contamination | 1 | 2020 | 71 | 0.150 |
Why?
| | Adverse Outcome Pathways | 1 | 2018 | 4 | 0.140 |
Why?
| | Electrocoagulation | 1 | 2018 | 35 | 0.140 |
Why?
| | Disinfection | 1 | 2020 | 128 | 0.140 |
Why?
| | Operating Rooms | 1 | 2018 | 148 | 0.120 |
Why?
| | Disease Outbreaks | 1 | 2020 | 424 | 0.120 |
Why?
| | Cystic Fibrosis | 1 | 2025 | 1124 | 0.110 |
Why?
| | Eosinophilic Esophagitis | 1 | 2019 | 328 | 0.110 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 2069 | 0.100 |
Why?
| | Young Adult | 4 | 2026 | 13727 | 0.100 |
Why?
| | Patient Care Team | 1 | 2018 | 667 | 0.100 |
Why?
| | Cohort Studies | 2 | 2023 | 5809 | 0.090 |
Why?
| | Risk Factors | 2 | 2023 | 10490 | 0.080 |
Why?
| | Registries | 1 | 2019 | 2205 | 0.080 |
Why?
| | Infant | 3 | 2024 | 9820 | 0.080 |
Why?
| | Phenotype | 1 | 2018 | 3172 | 0.080 |
Why?
| | Risk Assessment | 1 | 2018 | 3522 | 0.070 |
Why?
| | Infant, Newborn | 1 | 2019 | 6270 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2929 | 0.060 |
Why?
| | United States | 2 | 2023 | 15298 | 0.060 |
Why?
| | Prone Position | 1 | 2024 | 27 | 0.060 |
Why?
| | Supine Position | 1 | 2024 | 38 | 0.060 |
Why?
| | Chloride Channel Agonists | 1 | 2025 | 98 | 0.050 |
Why?
| | Pyrrolidines | 1 | 2025 | 109 | 0.050 |
Why?
| | Enzyme Replacement Therapy | 1 | 2024 | 16 | 0.050 |
Why?
| | Learning Curve | 1 | 2024 | 71 | 0.050 |
Why?
| | Quinolines | 1 | 2025 | 169 | 0.050 |
Why?
| | Drug Combinations | 1 | 2025 | 365 | 0.050 |
Why?
| | Pain Measurement | 1 | 2026 | 555 | 0.050 |
Why?
| | Quinolones | 1 | 2025 | 174 | 0.050 |
Why?
| | Ultrasonography | 1 | 2025 | 765 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2026 | 1037 | 0.040 |
Why?
| | Pyridines | 1 | 2025 | 560 | 0.040 |
Why?
| | Anesthesia | 1 | 2024 | 248 | 0.040 |
Why?
| | Prevalence | 1 | 2025 | 2795 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2904 | 0.030 |
Why?
| | Receptors, Transferrin | 1 | 1995 | 28 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1807 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2023 | 3345 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2025 | 2765 | 0.030 |
Why?
| | Malaria | 1 | 1995 | 66 | 0.030 |
Why?
| | Blood Glucose | 1 | 2024 | 2286 | 0.030 |
Why?
| | Iron | 1 | 1995 | 324 | 0.030 |
Why?
| | Mutation | 1 | 2024 | 4006 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2023 | 5948 | 0.020 |
Why?
| | Adult | 2 | 2021 | 39319 | 0.010 |
Why?
| | Democratic Republic of the Congo | 1 | 1995 | 33 | 0.010 |
Why?
| | Ferritins | 1 | 1995 | 66 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1995 | 206 | 0.010 |
Why?
| | Solubility | 1 | 1995 | 239 | 0.010 |
Why?
| | Health Status Indicators | 1 | 1995 | 161 | 0.010 |
Why?
| | Hemoglobins | 1 | 1995 | 361 | 0.010 |
Why?
| | Analysis of Variance | 1 | 1995 | 1312 | 0.010 |
Why?
| | Middle Aged | 1 | 1995 | 34658 | 0.000 |
Why?
|
|
Mark's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|